Skip to main content

Stephenson Brian C's Form 4 filing

Faeth Therapeutics, Inc. (FTH) · filed Jun 26, 2026

Accession no.
0001780030-26-000005
Filed
Jun 26, 2026
Trade date
Jun 24-26, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions. Open-market purchases total $401.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Stephenson Brian CCIK 0001780030Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 24, 2026Common StockPPurchaseAcquired+2,891$25.22F1+$72,911.0220,304Indirect
Jun 24, 2026Common StockPPurchaseAcquired+3,000$25.98F3+$77,94023,304Indirect
Jun 24, 2026Common StockPPurchaseAcquired+3,400$26.98F4+$91,73226,704Indirect
Jun 24, 2026Common StockPPurchaseAcquired+100$27.77+$2,77726,804Indirect
Jun 26, 2026Common StockPPurchaseAcquired+580$23.61F5+$13,693.827,384Indirect
Jun 26, 2026Common StockPPurchaseAcquired+4,212$24.90F6+$104,878.831,596Indirect
Jun 26, 2026Common StockPPurchaseAcquired+1,358$25.55F7+$34,696.932,954Indirect
Jun 26, 2026Common StockPPurchaseAcquired+100$26.39+$2,63933,054Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.50 to $25.435, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.58 to $26.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.61 to $27.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.27 to $24.1663, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.27 to $25.2405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.335 to $26.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)